 |
|
|
|
|
|
|
|
| 1 |
Refer to Glossary of Terms on page 38.
|
|
| 2 |
In 2004, we adopted FSP 106-2, “Accounting and Disclosure Requirements Related to Medicare Prescription Drug, Improvement and Modernization Act of 2003.”
|
|
| 3 |
In 2003, we adopted SFAS No.146, “Accounting for Costs Associated with Exit or Disposal Activities.”
|
|
| 4 |
In 2002, we adopted SFAS No.142, “Goodwill and Other Intangible Assets.”
|
|
| 5 |
In 2002, we adopted the fair value method provisions of SFAS 123, “Accounting for Stock-Based Compensation,” and we adopted SFAS No. 148, “Accounting for Stock-Based Compensation—Transition and Disclosure.”
|
|
| 6 |
In 2001, we adopted SFAS No. 133, “Accounting for Derivative Instruments and Hedging Activities.”
|
|
| 7 |
In 1998, we adopted SFAS No. 132, “Employers’ Disclosure about Pensions and Other Postretirement Benefits.”
|
|
| 8 |
In 1994, we adopted SFAS No. 115, “Accounting for Certain Investments in Debt and Equity Securities.”
|
|
|
|
|
|
|
|
